Baseline | Treatment | Follow-up | |||
---|---|---|---|---|---|
Time | −1w | 0w | 2w | 4w | 8w |
Assessment | 1st | 2nd | 3rd | 4th | |
Patients | |||||
Medical history | √ | ||||
Physical examination | √ | √ | √ | √ | |
Laboratory examination | √ | √ | |||
Sign informed consent | √ | ||||
Randomization | √ | ||||
Intervention and control | |||||
HCI group | 16 sessions of acupuncture | ||||
LOI group | |||||
MC group | 5 mg mosapride citrate tablet, three times a day | ||||
Outcomes | |||||
Number of defecating events per week | √ | √ | √ | √ | |
Shape and properties of stool | √ | √ | √ | √ | |
Intensity of defecating difficulty | √ | √ | √ | √ | |
PAC-QOL | √ | √ | √ | √ | |
SF-36 | √ | √ | |||
SAS | √ | √ | √ | ||
SDS | √ | √ | √ | ||
The time of the first spontaneous defecation | |||||
Safety assessment | |||||
Safety of electro-acupuncture | √ | √ | √ | ||
Adverse event | √ | √ | √ | ||
Trial evaluation | |||||
Patient’s compliance | √ | ||||
Rates of dropouts and withdrawals | √ |